Zencoxia 90mg Tablet contains Etoricoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, indicated for the management of pain and inflammation associated with various musculoskeletal and inflammatory conditions. Etoricoxib exerts its therapeutic effects by selectively inhibiting the COX-2 enzyme, thereby reducing the synthesis of prostaglandins responsible for pain and inflammation, while sparing COX-1, which helps minimize gastrointestinal adverse effects commonly seen with non-selective NSAIDs. Zencoxia is primarily prescribed for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis. It is also effective in managing postoperative pain and chronic musculoskeletal pain. The recommended dose of Zencoxia 90mg Tablet should be individualized based on the severity of symptoms and patient response, with caution exercised in patients with cardiovascular risk factors, renal impairment, or hepatic dysfunction. Common side effects may include headache, dizziness, gastrointestinal discomfort, and elevated blood pressure. Zencoxia is contraindicated in patients with hypersensitivity to Etoricoxib or other NSAIDs, active peptic ulcer disease, severe hepatic impairment, and established ischemic heart disease. Regular monitoring of renal and hepatic function is advised during prolonged therapy. Zencoxia 90mg Tablet offers targeted anti-inflammatory and analgesic benefits, improving patient quality of life in inflammatory conditions.